Article
Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) - 1 Jun 2017
Hidaka Noriko, Iwama Eiji, Kubo Naoki, Harada Taishi, Miyawaki Kohta, Tanaka Kentaro, Okamoto Isamu, Baba Eishi, Akashi Koichi, Sasaki Hiroyuki, Nakanishi Yoichi
Abstract excerpt
OBJECTIVES: The T790M and C797S mutations of the epidermal growth factor receptor gene (EGFR) confer resistance to first- and third-generation EGFR tyrosine kinase inhibitors (TKIs), respectively, in patients with non-small cell lung cancer (NSCLC) harboring activating mutations of EGFR. C797S has been identified in cis or in trans with T790M in tumor specimens from patients who experienced treatment failure with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
